CY1851A - Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasopastic disease - Google Patents

Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasopastic disease

Info

Publication number
CY1851A
CY1851A CY185196A CY185196A CY1851A CY 1851 A CY1851 A CY 1851A CY 185196 A CY185196 A CY 185196A CY 185196 A CY185196 A CY 185196A CY 1851 A CY1851 A CY 1851A
Authority
CY
Cyprus
Prior art keywords
aralkyl
aryl
interphenylene
disease
thrombotic
Prior art date
Application number
CY185196A
Other languages
English (en)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of CY1851A publication Critical patent/CY1851A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY185196A 1989-04-03 1996-03-08 Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasopastic disease CY1851A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33407089A 1989-04-03 1989-04-03

Publications (1)

Publication Number Publication Date
CY1851A true CY1851A (en) 1996-03-08

Family

ID=23305449

Family Applications (1)

Application Number Title Priority Date Filing Date
CY185196A CY1851A (en) 1989-04-03 1996-03-08 Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasopastic disease

Country Status (28)

Country Link
EP (1) EP0391652B1 (cs)
JP (1) JP2989213B2 (cs)
KR (1) KR0160508B1 (cs)
CN (1) CN1028529C (cs)
AT (1) ATE119903T1 (cs)
AU (1) AU632797B2 (cs)
CA (1) CA2012267C (cs)
CY (1) CY1851A (cs)
CZ (1) CZ285656B6 (cs)
DD (1) DD293353A5 (cs)
DE (1) DE69017735T2 (cs)
DK (1) DK0391652T3 (cs)
EG (1) EG19080A (cs)
ES (1) ES2069682T3 (cs)
FI (1) FI97543C (cs)
HK (1) HK110495A (cs)
HU (2) HUT54368A (cs)
IE (1) IE67274B1 (cs)
IL (1) IL93771A (cs)
MX (1) MX20132A (cs)
MY (1) MY106245A (cs)
NO (1) NO177425C (cs)
NZ (1) NZ232897A (cs)
PL (1) PL164345B1 (cs)
PT (1) PT93641B (cs)
RU (1) RU2059618C1 (cs)
SK (1) SK278865B6 (cs)
ZA (1) ZA902559B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5550248A (en) * 1990-11-29 1996-08-27 E.R. Squibb & Sons, Inc. Substituted stryl heterocyclic amido prostaglandin analogs
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5238951A (en) * 1991-02-01 1993-08-24 E. R. Squibb & Sons, Inc. Heterocyclic amido prostaglandin analogs
IE920039A1 (en) * 1991-02-01 1992-08-12 Squibb & Sons Inc Heterocyclic amido prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5162352A (en) * 1991-08-22 1992-11-10 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs
CA2081679A1 (en) * 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5281716A (en) * 1992-06-18 1994-01-25 Bristol-Myers Squibb Company Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
US5399725A (en) * 1993-05-27 1995-03-21 Bristol-Myers Squibb Co. 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same
US5539126A (en) * 1994-04-20 1996-07-23 Bristol-Myers Squibb Company Method for preparing homochiral maleimide intermediates, via silylation techniques
US5849766A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Carbamoyl substituted heterocycles
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
US5856584A (en) * 1997-08-06 1999-01-05 The Nutrasweet Company Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3, 3-dimethylbutanol
US5905175A (en) * 1998-05-20 1999-05-18 The Nutrasweet Company Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide
US6511999B2 (en) 2000-09-14 2003-01-28 Allergan, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
US6407250B1 (en) 2000-09-14 2002-06-18 Allergan Sales, Inc. Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
US6369089B1 (en) 2000-09-14 2002-04-09 Allergan Sales, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US7045634B2 (en) 2003-09-05 2006-05-16 Allergan, Inc. Prostamide receptor antagonists
CA2757480A1 (en) 2009-04-02 2010-10-07 Allergan, Inc. Prostaglandin e receptor antagonists
US20140187596A1 (en) * 2011-05-25 2014-07-03 Allergan, Inc. Fatty acid amide hydrolase inhihibitors for treating pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652576A (en) * 1985-10-18 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
US4663337A (en) * 1986-04-18 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease
CA2006355A1 (en) * 1988-12-23 1990-06-23 Philip M. Sher 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0391652A1 (en) 1990-10-10
NO901494L (no) 1990-10-04
EP0391652B1 (en) 1995-03-15
CZ285656B6 (cs) 1999-10-13
FI97543B (fi) 1996-09-30
HK110495A (en) 1995-07-14
KR900016197A (ko) 1990-11-12
PT93641A (pt) 1990-11-20
HU9002048D0 (en) 1990-08-28
CN1028529C (zh) 1995-05-24
FI97543C (fi) 1997-01-10
PL284600A1 (en) 1991-01-14
PL164345B1 (pl) 1994-07-29
AU5206490A (en) 1990-10-04
DE69017735D1 (de) 1995-04-20
NZ232897A (en) 1992-12-23
HU210713A9 (en) 1995-06-28
DK0391652T3 (da) 1995-04-03
CA2012267C (en) 2001-02-27
KR0160508B1 (ko) 1998-12-01
MY106245A (en) 1995-04-29
DD293353A5 (de) 1991-08-29
CN1046163A (zh) 1990-10-17
PT93641B (pt) 1996-06-28
ZA902559B (en) 1991-01-30
FI901645A0 (fi) 1990-04-02
MX20132A (es) 1994-01-31
CA2012267A1 (en) 1990-10-03
CZ158290A3 (cs) 1999-06-16
JP2989213B2 (ja) 1999-12-13
AU632797B2 (en) 1993-01-14
NO177425C (no) 1995-09-20
NO177425B (no) 1995-06-06
IE901095L (en) 1990-10-03
EG19080A (en) 1994-07-30
NO901494D0 (no) 1990-04-02
RU2059618C1 (ru) 1996-05-10
ES2069682T3 (es) 1995-05-16
IL93771A0 (en) 1990-12-23
SK158290A3 (en) 1998-04-08
IE67274B1 (en) 1996-03-20
DE69017735T2 (de) 1995-08-17
HUT54368A (en) 1991-02-28
ATE119903T1 (de) 1995-04-15
JPH02289579A (ja) 1990-11-29
IL93771A (en) 1995-06-29
SK278865B6 (sk) 1998-04-08

Similar Documents

Publication Publication Date Title
AU632797B2 (en) Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasopastic disease
EP0535928A3 (en) Process for producing intermediates for use in production of alkoxyiminoacetamides and intermediates to be used therein
IL80033A (en) 1-substituted 7-bridged-diazabicyclo-alkyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acids,related compounds and antibacterial pharmaceutical compositions containing them
SI0657428T1 (en) Preparation of 3,4,4-trisubstitutedpiperidinyl-n-alkylcarboxylates and intermediates, useful as opioid antagonists
EP0577847A4 (en) MORPHINANE DERIVATIVE AND USE IN MEDICINE.
ATE135363T1 (de) Nucleoside zur verwendung für die therapie
FI932445A0 (fi) Farmaceutiska foereningar
DE69311260D1 (de) Verfahren zur Herstellung von (E)-Alkoximino- oder Hydroxyiminoacetamidverbindungen und Zwischenprodukte
ZA899868B (en) 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ATE220904T1 (de) 2-phenyl-3-azoylbenzothiophene zur erhöhung der thrombomodulin expression
DK691288D0 (da) Cyclopropanderivater
PT86032A (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
GR3015704T3 (en) Glycerin derivative and its pharmacological use.
HUT57211A (en) Process for producing pyrrolo-pyrimidine derivatives, pharmaceutically acceptable salts thereof and pahrmaceutical compositions containing them as active components
ATE145911T1 (de) Inositol-phosphat-analog als kalzium- antagonistische substanz
DE69014261D1 (de) N-Azabicyclo[3.3.0]octanamide von aromatischen Säuren.
HUT56559A (en) Process for producing ascorbinic acid derivatives and pharma
EP0358880A3 (en) Use of retinoids
HUT58742A (en) Process for producing alpha-adrenerg-receptor antagonistic thieno-benzazepines and pharmaceutical compositions containing them
CA1271198C (en) 5,6-EPOXY-7-OXABICYCLOPTANE SUBSTITUTION DERIVATIVES OF PROSTAGLANDIN ANALOGS